CLGN

CollPlant Biotechnologies (CLGN)

About CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Details

Daily high
$2.07
Daily low
$2.00
Price at open
$2.01
52 Week High
$4.98
52 Week Low
$1.31
Market cap
25.6M
Dividend yield
0.00%
Volume
16,215
Avg. volume
19,090
P/E ratio
-1.97

CollPlant Biotechnologies News

Details

Daily high
$2.07
Daily low
$2.00
Price at open
$2.01
52 Week High
$4.98
52 Week Low
$1.31
Market cap
25.6M
Dividend yield
0.00%
Volume
16,215
Avg. volume
19,090
P/E ratio
-1.97